Zepp Health Corporation
ZEPP · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $540 | $427 | $280 | $433 |
| % Growth | 26.3% | 52.6% | -35.4% | – |
| Cost of Goods Sold | $334 | $273 | $176 | $274 |
| Gross Profit | $206 | $155 | $104 | $159 |
| % Margin | 38.2% | 36.2% | 37.3% | 36.8% |
| R&D Expenses | $77 | $80 | $90 | $80 |
| G&A Expenses | $50 | $31 | $0 | $0 |
| SG&A Expenses | $135 | $118 | $148 | $144 |
| Sales & Mktg Exp. | $85 | $86 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $212 | $198 | $238 | $224 |
| Operating Income | -$6 | -$44 | -$133 | -$65 |
| % Margin | -1.2% | -10.3% | -47.7% | -15% |
| Other Income/Exp. Net | -$4 | -$10 | -$9 | -$105 |
| Pre-Tax Income | -$11 | -$54 | -$143 | -$170 |
| Tax Expense | $1 | $2 | $1 | $99 |
| Net Income | -$12 | -$56 | -$143 | -$269 |
| % Margin | -2.1% | -13% | -51.2% | -62% |
| EPS | -2.92 | -14 | -37.28 | -66.96 |
| % Growth | 79.1% | 62.4% | 44.3% | – |
| EPS Diluted | -4.56 | -14 | -35.76 | -66.96 |
| Weighted Avg Shares Out | 4 | 4 | 4 | 4 |
| Weighted Avg Shares Out Dil | 4 | 4 | 4 | 4 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $2 | $4 | $6 |
| Interest Expense | $8 | $9 | $10 | $11 |
| Depreciation & Amortization | $9 | $5 | $0 | $4 |
| EBITDA | $6 | -$36 | -$130 | -$134 |
| % Margin | 1.2% | -8.5% | -46.5% | -31% |